#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bronchopulmonary aspergillosis Bladder cancer Adenovirus infection B-cell lymphoma recurrent Li-Fraumeni syndrome Alexander disease Squamous cell carcinoma of the oral cavity Hyperinsulinaemic hypoglycaemia Glomerulonephritis membranoproliferative Follicular lymphoma stage I Thrombocytopenia Anal cancer recurrent Osteosarcoma recurrent Mantle cell lymphoma refractory Squamous cell carcinoma of the vulva More trials…

    Learn about Rare Diseases

    Hairy cell leukaemia recurrent – Trials in Disease Noonan syndrome – Life with Disease Haemophagocytic lymphohistiocytosis – Life with Disease Fragile X syndrome – Diagnostics Glycogen storage disease type I – Treatment Short-bowel syndrome – Life with Disease Fabry’s disease Myelodysplastic syndrome with excess blasts – Life with Disease Lymphangiosarcoma MELAS syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Retinol Palmitate BNT327 SULBACTAM SODIUM Clioquinol VMX-C001 Dipyridamole Ethanol, Anhydrous Natalizumab Ecoo4 Tofacitinib Tebentafusp Amphotericine B, Liposome Ifosfamide Thiamine Garadacimab Atenolol Redasemtide Tropicamide Tulisokibart LTI-03 More therapies…

    Learn about Your Condition

    Addison's disease Habitual abortion Spinal osteoarthritis Brain injury Thalassaemia Ectopic pregnancy Ichthyosis Corneal graft rejection Ovarian cancer metastatic Tumour thrombosis Medulloblastoma recurrent Spermatocele Cystic fibrosis lung Supranuclear palsy Hypoparathyroidism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. KARDIOLOGIE LIBEREC s.r.o.

KARDIOLOGIE LIBEREC s.r.o.

Papirova 525/10, Liberec II-Nove Mesto, Liberec, 460 01, Czechia

Want to learn more about this study or check if you can participate? Contact us.

  • Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

    Recruiting

    3 1
    Bulgaria Czechia Denmark France Germany Greece +7

  • Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

    Recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    Investigated Drugs:
    • Maridebart Cafraglutide
    Austria Belgium Bulgaria Czechia Denmark Finland +12

  • A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic kidney disease
    • Arteriosclerosis
    Investigated Drugs:
    • Ziltivekimab
    Belgium Bulgaria Croatia Czechia Denmark Germany +12

  • A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation

    Not recruiting

    3 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Ziltivekimab
    Austria Belgium Bulgaria Croatia Czechia Denmark +18

  • Study of Orticumab in Adults with Previous Heart Attack and High Coronary Inflammation Measured by CT Scan

    Not recruiting

    2 1
    Czechia Hungary Italy Poland Romania Spain +1

  • Study on the Safety and Tolerability of Abelacimab Compared to Rivaroxaban in Patients with Atrial Fibrillation

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Abelacimab
    • Rivaroxaban
    Czechia Hungary Poland

  • Study on the Effects of AZD5462 for Patients with Stable Chronic Heart Failure

    Not recruiting

    2 1
    Investigated Diseases:
    • Cardiac failure chronic
    Investigated Drugs:
    • Azd5462
    Bulgaria Czechia Denmark Hungary The Netherlands Poland +1

  • Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Cagrilintide
    • Semaglutide
    Austria Belgium Bulgaria Czechia France Greece +8

  • Study on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments

    Not recruiting

    3 1
    Investigated Drugs:
    • Obicetrapib
    Bulgaria Croatia Czechia Denmark Finland Germany +7

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!